CBIO Earnings CRESCENT BIOPHARMA, INC.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–32 of 32
| FY 2024 | 2024-12-31 | -0.59 | 2025-02-13 | 10-K |
| Q3 2024 | 2024-09-30 | -0.48 | 2024-11-13 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.32 | 2024-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.04 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -0.58 | 2025-02-13 | 10-K |
| Q3 2024 | 2023-09-30 | -0.44 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.30 | 2024-08-08 | 10-Q |
| Q1 2025 | 2023-03-31 | -0.17 | 2025-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -0.89 | 2024-03-27 | 10-K |
| Q3 2023 | 2022-09-30 | -0.70 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.53 | 2023-08-02 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.28 | 2023-05-03 | 10-Q |
| FY 2023 | 2021-12-31 | -1.23 | 2024-03-27 | 10-K |
| Q3 2022 | 2021-09-30 | -0.90 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.56 | 2022-08-03 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.28 | 2022-04-28 | 10-Q |
| FY 2022 | 2020-12-31 | -1.12 | 2023-03-29 | 10-K |
| FY 2021 | 2019-12-31 | -1.34 | 2022-03-03 | 10-K |
| Q2 2016 | 2016-06-30 | -0.80 | 2016-08-04 | 10-Q |
| FY 2016 | 2015-12-31 | -0.47 | 2017-03-01 | 10-K |
| FY 2016 | 2015-09-30 | -0.38 | 2017-03-01 | 10-K |
| FY 2016 | 2015-06-30 | 0.51 | 2017-03-01 | 10-K |
| FY 2016 | 2015-03-31 | -0.37 | 2017-03-01 | 10-K |
| FY 2015 | 2014-12-31 | -0.39 | 2016-02-29 | 10-K |
| FY 2015 | 2014-09-30 | -0.35 | 2016-02-29 | 10-K |
| FY 2015 | 2014-06-30 | 0.39 | 2016-02-29 | 10-K |
| FY 2015 | 2014-03-31 | -0.30 | 2016-02-29 | 10-K |
| FY 2014 | 2013-12-31 | -8.87 | 2015-03-16 | 10-K |
| FY 2014 | 2013-09-30 | -3.00 | 2015-03-16 | 10-K |
| FY 2014 | 2013-06-30 | -3.70 | 2015-03-16 | 10-K |
| FY 2014 | 2013-03-31 | 0.04 | 2015-03-16 | 10-K |
| FY 2014 | 2012-12-31 | 0.33 | 2015-03-16 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.